ODE Software Task Force Will Assess Reviewer Consistency, Training
This article was originally published in The Gray Sheet
A recently formed FDA Office of Device Evaluation task force has been charged with ensuring uniformity among reviewers of software submissions, ODE staffer Joanna Weitershausen reported at the Health Industry Manufacturers Association's "Medical Device Software Conference" Oct. 14 in McLean, Virginia.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.